筛选糖尿病早期肾损伤检验指标的研究被引量：1

导出

摘要选择60例确诊为糖尿病早期肾损伤的患者作为观察组,60例体检健康者作为对照组,对比两组患者的同型半胱氨酸(Hcy)、胱抑素C(Cys C)、超敏C反应蛋白(hs-CRP)和糖化血红蛋白(Hb A1C)水平。结果发现观察组的4项指标水平明显高于对照组(P<0.05);联合分析4项指标对糖尿病早期肾损伤的阳性检出率要明显高于单项。结论通过检测分析Hcy、Cys C、hs-CRP、Hb A1C这4项指标水平对糖尿病肾损伤的早期诊断和预后治疗有十分重要的临床应用价值。

作者黄晶

机构地区湖北省浠水县人民医院检验科

出处《实用糖尿病杂志》 2015年第6期21-22,共2页 Journal of Practical Diabetology

关键词糖尿病早期肾损伤同型半胱氨酸胱抑素C 超敏C反应蛋白(hs-CRP) 糖化血红蛋白

分类号 R587.2 [医药卫生—内分泌] R446.1 [医药卫生—诊断学]

引文网络
相关文献

参考文献8

1尹娟.CysC、Hcy、HbAlc、hs—CRP在糖尿病早期肾损伤中的应用[J].中国实用医刊,2015,42(12):21-22. 被引量：10
2陈冬莲,郑身宏,刘首明,卢永亮,杨莹,宋兴贤.Cys-C、HbA1c、GA和U-mAlb/Cr检测对2型糖尿病早期肾损伤的诊断价值[J].国际检验医学杂志,2014,35(6):677-679. 被引量：16
3陈燕,赵敏,张家红,巴晶,韩玉淑,张丽霞.尿微量蛋白检查对糖尿病早期肾损伤的诊断价值[J].中华检验医学杂志,2003,26(9):562-564. 被引量：181
4蔡锦亮,洪桂清,陈静萍.CysC、Hcy、HbAlc、hs-CRP在糖尿病早期肾损伤中的应用研究[J].临床和实验医学杂志,2013,12(13):1017-1018. 被引量：15
5庄严,陈志友,王黎敏.血与尿胱抑素C在糖尿病早期肾损伤中的意义[J].中国实验诊断学,2014,18(8):1304-1306. 被引量：14
6Gruev T, Chakalarovski K, Stojceva-Taneva O, et al. Effects ofglucocorticoid immunosuppression on serum cystatin C Levels. J MedBiochem 2009;28(3) :191-196.
7Chen S,Shi JS, Yibulayin X, et al. Cystatin C is a moderatepredictor of acute kidney injury in the early stage of traumatic hemor-rhagic shock . Exp Ther Med 2015 ;10( 1) :237-240.
8Chew J S, Saleem M, Florkowski C M, et al. Cystatin C-Aparadigm of evidence based laboratory medicine. Clin Biochem Rev2008;29(2) : 47名2.

二级参考文献38

1杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量：1136
2叶任高主编.内科学:第5版[M].北京:人民卫生出版社,2002.466.
3Mussap M,Plebani M.Biochemistry and clinical role of human cystatin C[J].Crit Rev Clin Lab Sci,2004,41(5-6):467-550.
4Asci-Buturovi B,Cavaljuga S.Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients[J].Bosn J Basic Med Sci,2005,5(4):68-71.
5FiserD,Ritz E. Serum Cystatin C concentration as a marker of re- nal dysfunction in the elderly[J]. Am J Kidney Dis. 2001,37 (1): 79.
6Risch L, H erklotz R,Blumberg A, et al. Effects of glucocorticoid immunosuppression on sermcystatin C production by Hela cells [J]. Clin Chem,2001,47(11) :2055.
7Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexam-ethasone-induced increase in cystatin C production by Hela cells [J]. Scand J Clin Lab Invest,1996,55(7) :617.
8Fricker M,Wiesli P, Brandle M, et al. Impact of thyroid dysfunc- tion on serum cystatin C[J]. Kidney Int,2003,63(5) : 1944.
9Nina cimerman,Pikameskobrugljan,Marta Krasovec,et al. Twen W-four hour variations of cystain C and total cysteine proteinase inhibitory activity in sera from healthy subjects[J]. Clin Chin Ac- ta,2000,291:89.
10Chew JS, Saleem M, Florkowski CM, et al. Cystain C-A paradigm of evidence based laboratory medicine [J]. ClinBiochem Rew, 2008,29(2) .47.